HDAC11: A novel inflammatory biomarker in Huntington’s disease

Authors

  • Vishal Kumar ISF College of Pharmacy, Department of Pharmacology, Moga-142001, Punjab, India; affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, India https://orcid.org/0000-0003-3615-9374
  • Simranjit Kaur ISF College of Pharmacy, Department of Pharmacology, Moga-142001, Punjab, India; affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, India https://orcid.org/0000-0003-3093-3963
  • Lakshay Kapil ISF College of Pharmacy, Department of Pharmacology, Moga-142001, Punjab, India; affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, India https://orcid.org/0000-0002-1451-2264
  • Charan Singh ISF College of Pharmacy, Department of Pharmaceutics, Moga-142001, Punjab, India; affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, India https://orcid.org/0000-0002-1630-3183
  • Arti Singh ISF College of Pharmacy, Department of Pharmacology, Moga-142001, Punjab, India; affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab, India. E-mail: artiniper@gmail.com https://orcid.org/0000-0001-5168-4930

DOI:

https://doi.org/10.17179/excli2022-4741

Keywords:

Huntington’s disease (HD), GABA-ergic medium spiny neurons (MSNs), CAG (Cytosine, adenine, Guanine), Huntington (Htt) gene, polyglutamine (poly Q), mutant Huntington (mHtt), BDNF (brain-derived neurotrophic factor), tetrabenazine (TBZ)

Downloads

Additional Files

Published

2022-03-24

How to Cite

Kumar, V., Kaur, S., Kapil, L., Singh, C., & Singh, A. (2022). HDAC11: A novel inflammatory biomarker in Huntington’s disease. EXCLI Journal, 21, 647–650. https://doi.org/10.17179/excli2022-4741

Issue

Vol. 21 (2022)

Section

Letters to the editor

Categories

License

Copyright (c) 2022 Vishal Kumar, Simranjit Kaur, Lakshay Kapil, Charan Singh, Arti Singh

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish in this journal agree to the following terms:

  • The authors keep the copyright and grant the journal the right of first publication under the terms of the Creative Commons Attribution license, CC BY 4.0. This licencse permits unrestricted use, distribution and reproduction in any medium, provided that the original work is properly cited.
  • The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
  • Because the advice and information in this journal are believed to be true and accurate at the time of publication, neither the authors, the editors, nor the publisher accept any legal responsibility for any errors or omissions presented in the publication. The publisher makes no guarantee, express or implied, with respect to the material contained herein.
  • The authors can enter into additional contracts for the non-exclusive distribution of the journal's published version by citing the initial publication in this journal (e.g. publishing in an institutional repository or in a book).